Just months after it started trading on the Nasdaq in June 2021, the company was valued as high as $5.8 billion. As of Friday ...
As part of the federal process to address its money troubles, the beleaguered biotech firm is looking to sell off its assets.
Various factors seem to have contributed to 23andMe’s decline. Its kits are a one-time product, so there is little prospect ...
Following the firm’s bankruptcy, researchers hope that they will be able to continue accessing the valuable data set even if ...
Me, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale.
Genetic testing company 23andMe's bankruptcy has led to a new consumer privacy issue: what happens to the DNA of millions of ...
Explore more
Would you trust a company with your most personal data — your DNA — if it was on the brink of collapse? Millions of 23andMe ...
The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results